explore -WSS

explore

author：Wikipedia 2025-10-01 15:30:36 - browse：853

STAT

There’s nothing better than a beautiful spring day after a long, cold winter. But there’s nothing worse than having that day ruined by the sneezing, sniffling, and itching that come with seasonal allergies.

Scientists don’t actually completely understand why we get seasonal allergies. The best estimation is that they’re an immune response to toxins in the natural environment that pollen also happens to trigger. That immune response begins with the production of IgE antibodies to combat the pollen. The antibodies link up with mast cells, and together they’re a ticking time bomb. When more allergens come along, they activate all those horrible symptoms.

In the new episode of “Boddities,” we dive into how this response happens, and what you can do about it to ease the symptoms and enjoy the season.

Watch other “Boddities” episodes:

Related: Watch: Episode 6: What happens to the brain when we get scared?

Related: Watch: Episode 4: Why do our ears pop?

Related: Episode 5: Why do bright lights make us see spots?

Previous article： DIEP, the 'gold standard' of breast reconstruction, is under threat
Next article： An inside look at PIPEs, biotech's buzzy new financing tool

hotspot

WSS

Abortion pill mifepristone to soon be dispensed at CVS, Walgreens

What causes rare myocarditis in young men after Covid vaccines?

Readout Newsletter: Ironwood, Pfizer, FogPharma updates

Rise in cancer among younger people worries and puzzles doctors

Will the FTC rein in IQVIA's health data empire?

RaDonda Vaught to speak at CommonSpirit event on patient safety

knowledge

explore

Related: Watch: Episode 6: What happens to the brain when we get scared?

Related: Watch: Episode 4: Why do our ears pop?

Related: Episode 5: Why do bright lights make us see spots?

knowledge

ChatGPT in medicine: STAT answers readers' burning questions

Kenai launches with $82 million for Parkinson’s stem cell therapy

Hepatitis C has a cure — but many Americans still lack access to it

The haunting brain science of long Covid

Peter Hotez and the public health issue of online harassment

Pfizer highlights cancer drugs it thinks could reignite investor interest

Medical records are filled with copy

AstraZeneca loses challenge to Medicare drug price negotiation

Bright Health sells Medicare Advantage business to Molina

Truvian presents data for its desktop blood

explore

A Q&A with Aletha Maybank, AMA’s chief health equity officer

What to watch for from Zogenix and Amicus clinical trials

UHS says company favors patients whose insurance pays more

How doctors’ personal politics affect patients

Device maker Teleflex to acquire urology company for $600M

A new crop of companies is reshaping the health data economy

explore

knowledge

hotspot

entertainment